Page last updated: 2024-12-04

bentiromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

bentiromide: chymotrypsin labile peptide used diagnostically as an index of exocrine pancreas function [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bentiromide : The dipeptide obtained by condensation of N-benzoyl-L-tyrosine with 4-aminobenzoic acid. Used as a noninvasive screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy, it is given by mouth: the amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6957673
CHEMBL ID1200368
CHEBI ID31263
SCHEMBL ID151634
MeSH IDM0049427

Synonyms (61)

Synonym
chebi:31263 ,
bentiromidum
4-[(n-benzoyl-l-tyrosyl)amino]benzoic acid
n-benzoyl-l-tyrosyl-p-aminobenzoate
4-(n-benzoyl-l-tyrosylamino)benzoic acid
bentiromido
bt-paba
brn 2910938
benzoic acid, 4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)-, (s)-
einecs 253-349-8
chymex
(s)-4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic acid
(s)-p-(alpha-benzamido-p-hydroxyhydrocinnamamido)benzoic acid
bentiromidum [inn-latin]
e-2663
bentiromido [inn-spanish]
benzoyltyrosyl-p-aminobenzoic acid
ro 11-7891
e 2663
bentiromide [usan:ban:inn:jan]
DB00522
bentiromide
btpaba
37106-97-1
btpaba, pft
btpaba pft
btpabapft
CHEMBL1200368
btpaba-pft
S4388
unii-239if5w61j
239if5w61j ,
bentiromide [usan:inn:ban:jan]
bentiromide [inn]
bentiromide [usan]
bentiromide [orange book]
bentiromide [mart.]
bentiromide [mi]
bentiromide [jan]
bentiromide [vandf]
bentiromide [who-dd]
SCHEMBL151634
DTXSID2048377
bz-tyr-4-abz-oh
AB01566933_01
4-[(2s)-3-(4-hydroxyphenyl)-2-(phenylformamido)propanamido]benzoic acid
sr-01000883958
SR-01000883958-1
mfcd00055768
SW219774-1
(s)-4-(2-benzamido-3-(4-hydroxyphenyl)propanamido)benzoic acid
(4-[[(2s)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic acid
Q793082
4-(n-benzoyl-l-tyrosyl)aminobenzoic acid
HY-B1493
CS-0013190
CCG-268691
MS-26906
4-[[(2s)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic acid
4-(n-benzoyl-l-tyrosyl)aminobenzoicacid
AKOS040741308

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Plasma p-aminobenzoic acid (PABA) and xylose concentrations were determined before, and at 30, 60, 90, 120, 150, and 180 minutes after, a solution of bentiromide (1 g/100 ml) and D-xylose (10 g/100 ml) was given orally at a dosage of 5 ml/kg of body weight."( Bentiromide:xylose test in healthy cats.
Johnson, SE; Rogers, WA; Sherding, RG; Stradley, RP, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
diagnostic agentA substance administered to aid diagnosis of a disease.
indicatorAnything used in a scientific experiment to indicate the presence of a substance or quality, change in a body, etc.
reagentA substance used in a chemical reaction to detect, measure, examine, or produce other substances.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dipeptideAny molecule that contains two amino-acid residues connected by peptide linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Bile salt export pumpHomo sapiens (human)IC50 (µMol)234.80000.11007.190310.0000AID1449628
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (22)

Processvia Protein(s)Taxonomy
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1449628Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method2012Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 40, Issue:12
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (143)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990103 (72.03)18.7374
1990's29 (20.28)18.2507
2000's8 (5.59)29.6817
2010's3 (2.10)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (4.67%)5.53%
Reviews14 (9.33%)6.00%
Case Studies1 (0.67%)4.05%
Observational0 (0.00%)0.25%
Other128 (85.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]